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Comparison of Three Magnetization Transfer Ratio
Parameters for Assessment of Intestinal Fibrosis in
Patients with Crohn’s Disease
Jixin Meng, MD1*, Siyun Huang, MD1*, CanHui Sun, MD1, Zhong-wei Zhang, MD, PhD2, Ren Mao, MD3,
Yan-hong Yang, MD1, Shi-Ting Feng, MD1, Zi-ping Li, MD1, XueHua Li, MD1
Departments of 1Radiology and 3Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China; 2Mallinckrodt Institute
of Radiology, Washington University School of Medicine, St. Louis, MO, USA

Objective: To establish a novel standardized magnetization transfer ratio (MTR) parameter which considers the element of the
normal bowel wall and to compare the efficacy of the MTR, normalized MTR, and standardized MTR in evaluating intestinal
fibrosis in Crohn’s disease (CD).
Materials and Methods: Abdominal magnetization transfer imaging from 20 consecutive CD patients were analyzed before
performing elective operations. MTR parameters were calculated by delineating regions of interest in specified segments on MTR
maps. Specimens with pathologically confirmed bowel fibrosis were classified into one of four severity grades. The correlation
between MTR parameters and fibrosis score was tested by Spearman’s rank correlation. Differences in MTR, normalized MTR,
and standardized MTR across diverse histologic fibrosis scores were analyzed using the independent sample t test or the MannWhitney U test. The area under the receiver operating characteristic curve (AUC) was computed to test the efficacies of the
MTR parameters in differentiating severe intestinal fibrosis from mild-to-moderate fibrosis.
Results: Normalized (r = 0.700; p < 0.001) and standardized MTR (r = 0.695; p < 0.001) showed a strong correlation with
bowel fibrosis scores, followed by MTR (r = 0.590; p < 0.001). Significant differences in MTR (t = -4.470; p < 0.001), normalized
MTR (Z = -5.003; p < 0.001), and standardized MTR (Z = -5.133; p < 0.001) were found between mild-to-moderate and severe
bowel fibrosis. Standardized MTR (AUC = 0.895; p < 0.001) had the highest accuracy in differentiating severe bowel fibrosis
from mild-to-moderate bowel wall fibrosis, followed by normalized MTR (AUC = 0.885; p < 0.001) and MTR (AUC = 0.798; p
< 0.001).
Conclusion: Standardized MTR is slightly superior to MTR and normalized MTR and therefore may be an optimal parameter for
evaluating the severity of intestinal fibrosis in CD.
Keywords: Magnetization transfer imaging; Crohn’s disease; Fibrosis; Magnetic resonance imaging

INTRODUCTION
Crohn’s disease (CD) is a chronic relapsing inflammatory
bowel disease characterized by transmural inflammation and
may manifest with varying degrees of fibrosis resulting in
intestinal narrowing or even obstruction. Irreversible bowel

obstruction resulting from severely fibrotic bowel stricture
commonly requires surgical excision (1). Therefore, an exact
differentiation among various degrees of intestinal fibrosis
and an accurate distinction of severely fibrotic bowel walls
from mild-to-moderately fibrotic bowel walls is crucial and
urgently needed for ensuring appropriate clinical treatment.
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Recently, magnetization transfer (MT) magnetic
resonance imaging (MRI), referred to as MT imaging (MTI),
is a noninvasive method for accurately detecting and
distinguishing varying degrees of intestinal fibrosis in CD
(2-4). Bowel fibrosis in CD is characterized by excessive
collagen accumulation in the extracellular matrix (5). As
such, the concentration of macromolecules in the fibrotic
intestinal walls, such as collagen, determines the image
contrast of MTI (6). The concentration of macromolecules in
the bowel walls can be quantitatively reflected indirectly by
the MT ratio (MTR) (7, 8). The MTR increases with increasing
bowel fibrosis in CD. A high MTR of the affected bowel wall,
close to the muscle with the highest MTR in human tissue,
indicates severe fibrosis (2). However, a low MTR may be
detected in severely fibrotic bowel walls with a similarly low
MTR of muscle in some cases due to individual differences.
To facilitate the comparison between individual cases, the
MTR of the affected bowel wall was divided by the MTR of
the muscles on the same image to obtain a normalized MTR
to minimize individual variation (3, 9). This normalized
MTR also showed a high accuracy in detecting and further
stratifying bowel fibrosis in CD (9). However, the approach
using MTR or normalized MTR on the pathologic bowel wall
to directly assess fibrosis does not take into account the
already existing MTR of the normal intestine. It is noteworthy
that the MTR of the normal bowel wall increases slightly due
to the presence of intestinal smooth muscle (2, 7). However,
it remains unclear whether or not including the MTR of the
normal intestine could yield a new MTR parameter that may
show greater accuracy in evaluating bowel fibrosis. A more
accurate parameter for monitoring fibrosis progression will
promote research on specific therapeutic strategies for bowel
fibrosis. Therefore, the purpose of this study was to establish
a new MTR parameter (standardized MTR) that includes the
MTR of the normal intestine and to compare its efficacy with
those of MTR and normalized MTR in assessing bowel fibrosis
in patients with CD.

MATERIALS AND METHODS
Patients
The Institutional Ethics Review Board approved this
prospective observational study, and patients with CD who
underwent magnetic resonance enterography (MRE) provided
written informed consent prior to study participation.
From July 2015 to April 2017, 22 consecutive CD patients
who underwent MRE and surgical resection were recruited
kjronline.org
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by the Inflammatory Bowel Disease Center. The inclusion
criteria were as follows: 1) patients over 18 years of age
with a preoperative diagnosis of strictured CD according
to well-recognized clinical, endoscopic, imaging, and
histological criteria; 2) underwent conventional MRE
examination within 15 days before elective operation; and 3)
had matching locations between histological examinations
and MRE. The exclusion criteria were as follows: 1)
insufficient MTI quality or 2) another concurrent intestinal
disease.
MRI Protocol
As described in previous studies (10-12), patients
took orally administered polyethylene glycol electrolyte
dispersion after 6–8 hours of fasting to clean the intestinal
tract. Then, 1600–2000 mL of 2.5% mannitol solution was
given 1 hour before MRI to fill the small bowel. Next, 10 mg
of raceanisodamine hydrochloride (Minsheng Pharmaceutical
Group, Hangzhou, China) was injected intramuscularly
into the buttock 10 minutes before scanning to inhibit
gastrointestinal peristalsis.
All MRE scans were performed using a 3T superconductive
MR device (Magnetom Trio; Siemens Healthineers, Erlangen,
Germany) equipped with multi-channel phased-array body
coils and spinal surface coils. Axial breath-hold MTI was
performed using two gradient-echo data sets with and
without pre-saturation pulse (frequency offset: 1.2 kHz,
duration: 9984 μs, effective flip angle: 500°, bandwidth:
192 Hz, slice thickness: 4 mm). The conventional MRE
sequences included axial and coronal breath-hold halfFourier acquisition single-shot turbo spin-echo T2-weighted
(repetition time [TR]: 1200 ms; echo time [TE]: 87 ms;
flip angle: 160°; matrix: 320 x 194; slice thickness: 4 mm)
and coronal breath-hold fat-suppressed fast low angle
shot T1-weighted (TR: 210 ms; TE: 2.18 ms; flip angle:
70°; matrix: 320 x 200; slice thickness: 4 mm) images.
After intravenous injection of 0.2 mL/kg gadopentetate
dimeglumine (Beilu Pharmaceuticals, Beijing, China)
at a rate of 2 mL/s, multiple coronal dynamic contrastenhanced, fat-suppressed, three-dimensional volumetric
interpolated breath-hold examinations (TR: 4.37 ms; TE:
1.37 ms; flip angle: 1°; matrix: 320 x 217; slice thickness:
2 mm) were performed at 15, 40, 65, and 90 seconds from
the beginning of the injection.
MRI Analysis
MTRs were calculated using the following equation: MTR
291
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= (1 - Msat / M0) x 100%, where Msat and M0 indicate signal
intensities acquired with and without off-resonance prepulse saturation, respectively (2, 6, 7). MTR maps were
produced using an in-house MATLAB script (MathWorks,
Natick, MA, USA). The involved bowel segments were
marked for region-by-region evaluation by a senior
radiologist with 16 years of experience performing
intestinal MRI and who was not blinded to the clinical,
biochemical, and pathological data. Then, 3 MTR parameters
were measured and calculated by a radiologist with 6 years
of experience performing bowel MRI and who was blinded
to the clinical, biochemical test, and pathological data.
Three irregular regions of interest (ROIs) with different
sizes were separately drawn on the pathologic bowel walls,
normal bowel walls, and the psoas or gluteal muscle with
a total of nine ROIs at the same slice. The normal bowel
segment was defined as the bowel wall with a thickness of
< 3 mm, with an isointensity on T2-weighted and contrastenhanced images, and without the presence of a lesion in
a series of clinical data. Then, the average MTR of every
tissue was calculated. The normalized MTR was calculated
according to the following equation (3, 9): normalized MTR
= MTRpathologic bowel wall / MTRmuscle. Considering the impact of
a slight increase in the MTR of the normal bowel wall, we
established a new MTR parameter according to the following
equation and called this the standardized MTR: standardized
MTR = (MTRpathologic bowel wall - MTRnormal bowel wall) / (MTRmuscle MTRnormal bowel wall). This parameter was expected to eliminate
the influence of background MTR of the normal bowel wall
and to avoid overestimating the severity of bowel fibrosis.
The mean areas of the ROIs in the affected bowel walls,
normal bowel walls, and the psoas or gluteal muscle were
97.52 ± 79.42 mm2, 38.51 ± 15.57 mm2, and 405.92 ±
116.61 mm2, respectively.
Intestinal Segment Selection for Corresponding
Histological Evaluation and MRI Assessment
Matched assessments between specimens and MRI were
performed by a radiologist with 16 years of experience

performing intestinal MRI and who was not blinded to the
clinical, laboratory, imaging, and histopathological data.
Matching locations between the resected bowel segments
and MRI were identified using anatomic landmarks (surgically
resected margins, ileocecal valve, or appendix) or gross
lesions (bowel fistula or adhesion) (9, 13-15). A total of 2–4
specimens were obtained from each patient according to
the number of lesions and the extent of the disease.
Histopathological Assessment
The whole specimen was embedded in paraffin after
fixing in formalin and cut into slices 4-μm thick. All
specimens were stained with Masson’s trichrome staining
for histologic fibrosis scoring. The histologic slices from
areas with the most severe fibrosis were graded from 0–3
using a semi-quantitative scoring system by an experienced
gastrointestinal pathologist with 10 years of experience in
intestinal pathology and who was blinded to the clinical
and imaging information (9, 16-18) (Table 1).
Statistical Analysis
Statistical analysis of the comparisons was performed
using SPSS (version 20; IBM Corp., Armonk, NY, USA). A
p value < 0.05 was considered statistically significant.
Continuous variables were described as means ± standard
deviation (normal distribution data) or medians and
interquartile ranges (abnormal distribution data), and
categorical variables were described as percentages and
absolute values. The correlations between the three MTR
parameters and fibrosis scores were tested by Spearman’s
rank correlation. Differences in MTR, normalized MTR, and
standardized MTR among diverse histologic fibrosis scores
were tested using the independent sample t test or the
Mann–Whitney U test according to the data type. The area
under the receiver operating characteristic (ROC) curve
(AUC) was utilized to test the efficiency of the three MTR
parameters in differentiating severe intestinal fibrosis from
mild-to-moderate intestinal fibrosis.

Table 1. Histologic Scores for Assessing Severity of Fibrosis in Crohn’s Disease
Score
0 (none)
1 (mild)
2 (moderate)
3 (severe)
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Fibrosis
No fibrosis
Minimal fibrosis in submucosa or subserosa
Increased submucosal fibrosis; septa extending into muscularis propria and/or septa extending through muscularis
propria; increase in subserosal collagen
Significant transmural scar; marked subserosal collagen
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RESULTS
Demographic and Clinical Data
Twenty-two CD patients underwent MRE examination.
Two patients, one with unsatisfactory MTI quality and one
with a combined carcinoma of the intestine, were excluded.
Table 2. Demographic and Clinical Characteristics of Patients
n = 20
Sex (female/male)
12/8
Age, mean ± SD (years)
30.5 ± 9.2
Disease duration, mean ± SD (months)
55.6 ± 45.8
Interval between MRI and surgery,
6.4 ± 4.8
mean ± SD (days)
<7
12
7–15
8
Surgical type, n (%)
Ileocolectomy
14/20 (70)
Partial small bowel resection
6/20 (30)
Number of bowel specimens, n (%)
Jejunum
5/63 (7.9)
Proximal ileum
10/63 (15.9)
Terminal ileum
31/63 (49.2)
Colon
17/63 (27.0)
Histological fibrosis of bowel specimens, n (%)
Mild
6/63 (9.5)
Moderate
35/63 (55.6)
Severe
22/63 (34.9)
CDAI, mean ± SD
269.14 ± 100.40
CRP, mean ± SD (mg/L)
41.34 ± 17.44
ESR, mean ± SD (mm/h)
36.60 ± 18.98

1.00

1.90

0.90

1.40

0.80
0.70
0.60
0.50

Histological Assessment
Of the 63 bowel specimens, 46 were from the most
strictured segments in the jejunum (n = 5), proximal ileum
(n = 10), and terminal ileum (n = 31), and 17 were from
colonic lesions. Regarding the histological fibrosis of the 63
specimens, 6 had mild, 35 had moderate, and 22 had severe
fibrosis (Table 2).
Comparison of the Efficacies among the Three MTR
Parameters for Assessing Bowel Fibrosis
The normalized MTR (r = 0.700; p < 0.001) and
standardized MTR (r = 0.695; p < 0.001) showed a strong
correlation with bowel fibrosis scores, followed by MTR
(r = 0.590; p < 0.001) (Fig. 1). Significant differences in
MTR (t = -4.470; p < 0.001), normalized MTR (Z = -5.003;
p < 0.001), and standardized MTR (Z = -5.133; p < 0.001)
were found between mildly-to-moderately and severely
(Fig. 2) fibrotic intestinal walls (Fig. 3, Table 3). Moreover,
there was no overlap in the ranges of standardized MTR

0.50

0.90

0.40
MTR

Standardized MTR

Normalized MTR

CDAI = Crohn’s disease activity index, CRP = C-reactive protein,
ESR = erythrocyte sedimentation rate, MRI = magnetic resonance
imaging, SD = standard deviation

Ultimately, 20 patients (8 males, 12 females; average
age: 30.5 ± 9.2 years) with 63 samples met the inclusion
criteria and were recruited in this study. Statistically, the
mean disease duration was 55.6 ± 45.8 months, and the
mean interval between MRI and surgery was 6.4 ± 4.8
days, with 12 patients with an interval shorter than 7 days
and 8 patients with an interval between 7 and 15 days.
Fourteen (70%) patients underwent ileocolectomy and six
(30%) patients underwent partial small bowel resection. In
addition, the CD activity parameter was 269.14 ± 100.40,
the C-reactive protein level was 41.34 ± 17.44 mg/L, and
the erythrocyte sedimentation rate was 36.60 ± 18.98 mm/h.

0.40

0.30

-0.10
-0.60

0.40

0.20

-1.10
1

2

3

Bowel fibrosis scores

1

2

3

1

Bowel fibrosis scores

A
B
Fig. 1. Correlation between three MTRs and histologic bowel fibrosis scores.

2

3

Bowel fibrosis scores

C

Normalized MTR (r = 0.700; p < 0.001) (A) and standardized MTR (r = 0.695; p < 0.001) (B) were strongly correlated with bowel fibrosis scores,
followed by MTR (r = 0.590; p < 0.001) (C). MTR = magnetization transfer ratio
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between mild-to-moderate and severe bowel fibrosis (Fig. 3),
demonstrating that standardized MTR was superior to MTR
and normalized MTR.
The standardized MTR (AUC = 0.895; 95% confidence
interval [CI], 0.807–0.982; p < 0.001) had the highest
accuracy in differentiating severe bowel wall fibrosis
from mild-to-moderate bowel wall fibrosis, followed by
normalized MTR (AUC = 0.885; 95% CI, 0.803–0.966; p <

A

0.001) and MTR (AUC = 0.798; 95% CI, 0.682–0.914; p <
0.001) (Fig. 4).

DISCUSSION
In this study, we found that the standardized MTR, which
was strongly correlated with histologic bowel fibrosis scores
and had the highest accuracy in differentiating severe

B

C
100
90
80
70
60
50
40
30
20
10
0

D

E

F

G
Fig. 2. 36-year-old woman with severe Crohn’s disease in terminal ileum.

A. Axial T2-weighted image and (B) axial contrast-enhanced T1-weighted image show marked bowel wall thickening and luminal stenosis with
hyper-enhancement at terminal ileum (arrows). C-E. Axial MT imaging without (C) and with (D) MT pulse as well as pseudo-color MTR map
(E) indicate that MT effect of terminal ileum (arrows; ROIs, 1–3; MTR, 44.2%; yellow-blue) is higher than that of normal small intestinal wall
(hollow arrows; ROIs, 4–6; MTR, 26.0%; dark blue) and close to that of skeletal muscles (arrowheads; ROIs, 7–9; MTR, 52.0%; yellow). Averages
of standardized MTR and normalized MTR of involved bowel wall are 0.70 and 0.85, respectively. F. Gross specimen from surgical excision
demonstrates marked thickening of bowel wall with obvious luminal stenosis (arrows). G. Masson’s trichrome staining (magnification: x 20)
displays severe intestinal fibrosis (arrow; blue area) with fibrosis score of 3. MT = magnetization transfer, ROI = region of interest
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0.60
0.40
0.20
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fibrosis

Severe
fibrosis

0.80
0.60
0.40
0.20
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fibrosis

Bowel fibrosis

Severe
fibrosis

Mild-to-moderate
fibrosis

Bowel fibrosis

Severe
fibrosis

Bowel fibrosis

A
B
C
Fig. 3. Box plots showing differences of three MTRs between mild-to-moderate and severe bowel fibrosis.

Significant differences in MTR (t = -4.470; p < 0.001) (A), normalized MTR (Z = -5.003; p < 0.001) (B), and standardized MTR (Z = -5.133; p <
0.001) (C) were found between mild-to-moderate and severe bowel fibrosis.

Table 3. Comparison of MTR Parameters between Mild-toModerate and Severe Bowel Fibrosis

1.0

Mild-to-Moderate
Severe
P
Fibrosis
Fibrosis
MTR (%)
34.730 ± 6.449
41.910 ± 5.313 < 0.001
Normalized MTR 0.734 (0.574–0.894)* 0.874 ± 0.062 < 0.001
Standardized MTR 0.469 (0.179–0.759)* 0.747 ± 0.142 < 0.001

intestinal fibrosis from mild-to-moderate intestinal fibrosis,
was an optimal parameter for evaluating the severity of
intestinal fibrosis compared with MTR and normalized MTR.
MTI has been reported as a non-invasive method that
can be effectively used for assessing intestinal fibrosis in
CD patients (7). The quantitative parameters of MTI (MTR
and normalized MTR) were both reported to be capable of
characterizing the severity of bowel fibrosis in animal or
human CD (2, 3, 7, 9). Our preliminary results and those
of other studies showed that a higher MTR or normalized
MTR of the thickened intestinal wall, similar to that of
the muscle presenting the highest MTR in human tissue,
indicated a higher fibrotic composition of the lesion (2,
3, 9). However, in clinical practice, sometimes a relatively
higher MTR or normalized MTR might be observed in the
normal intestinal wall, which may hinder interpretations of
the result. Other physiological macromolecules within the
normal bowel wall, such as smooth muscle, would slightly
increase the MTR or normalized MTR and would influence
the accurate assessment of the severity of bowel fibrosis.
This manifestation attracted our attention and provided
the idea to include the already existing MTR of the normal
intestine during the evaluation process when using MTI
kjronline.org
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Sensitivity

*Normalized and standardized MTR with mild-to-moderate fibrosis
of abnormal distribution were described as median (interquartile
range). MTR = magnetization transfer ratio

0.8

0.6

0.4
Source of curve
0.2

0.0
0.0

MTR
Normalized MTR
Standardized MTR
Reference line
0.2

0.4

0.6

0.8

1.0

1-specificity

Fig. 4. ROC curve analysis for differentiating severe bowel
fibrosis from mild-to-moderate fibrosis. ROC curve analysis
shows that standardized MTR is highly accurate with AUC of 0.895
in distinguishing severe intestinal fibrosis from mild-to-moderate
intestinal fibrosis, followed by normalized MTR (AUC = 0.885) and MTR
(AUC = 0.798). AUC = area under ROC curve, ROC = receiver operating
characteristic

to quantitatively assess bowel fibrosis. Given that severe
fibrotic bowel stricture leading to intestinal obstruction in
CD patients invariably requires surgical excision and that
non-severely fibrotic intestinal stricture may be relieved by
medical treatment (1), it is of great importance for both
radiologists and clinicians to select the most appropriate
MTR parameter to evaluate the degree of intestinal
fibrosis for guiding an individualized therapy. To minimize
differences between individuals and to more accurately
295
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diagnose bowel fibrosis, we developed a new parameter
(standardized MTR) to quantify the severity of bowel
fibrosis and to determine whether standardized MTR was
superior to MTR or normalized MTR.
Our study indicated that standardized MTR, MTR, and
normalized MTR were able to assess intestinal fibrosis in CD
patients. The correlation strength of MTR and normalized
MTR with bowel fibrosis in our study was similar to those
reported previously (r = 0.74–0.77) (2, 9). As we expected,
standardized MTR was one of the two parameters showing a
strong correlation with histologic bowel fibrosis score in our
study, and it showed the highest accuracy in differentiating
severe intestinal fibrosis from mild-to-moderate intestinal
fibrosis, when compared with normalized MTR and MTR.
It was also noteworthy that there was no overlap in the
interquartile ranges of standardized MTRs between mild-tomoderate and severe bowel fibrosis, whereas the other two
parameters had overlaps that should be considered when
applying them in clinical practice. This result confirmed the
ability of standardized MTR to accurately stratify the severity
of bowel fibrosis. Moreover, standardized MTR helped to
better minimize differences between individuals and was
beneficial in comparing between patients with different
severities or in the same patient before and after treatment.
There are several limitations in our study. First, a relatively
smaller sample of bowel segments with varying degrees of
fibrosis were included in this study, and we did not include
normal bowel segments, as only bowel segments with severe
stricture were likely to be surgically resected. Second, it was
difficult to accurately perform a point-by-point comparison
of peristaltic bowels on MRI with the histopathologic
specimens. Fortunately, by eliminating peristalsis of the
bowel and shortening the time interval between the MRI
examination and surgery, we believe that this problem was
partially solved. Third, bias may have resulted from the
absence of intra- or inter-observer variation in ROI selection
as the distribution of varying degrees of intestinal fibrosis
often shows inhomogeneity. However, we delineated three
ROIs on the target bowel wall to reduce this bias.
In conclusion, standardized MTR was superior to MTR and
normalized MTR and could be an optimal parameter for the
quantitative assessment of the severity of bowel fibrosis in
CD patients.
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